Paradigm Biopharmaceuticals Limited (ASX:PAR)
0.3050
-0.0100 (-3.17%)
Jan 30, 2026, 3:59 PM AEST
-34.41% (1Y)
| Market Cap | 136.55M |
| Revenue (ttm) | n/a |
| Net Income | -18.77M |
| EPS | -0.06 |
| Shares Out | 433.50M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 962,244 |
| Average Volume | 922,314 |
| Open | 0.3150 |
| Previous Close | 0.3150 |
| Day's Range | 0.3050 - 0.3170 |
| 52-Week Range | 0.2550 - 0.6600 |
| Beta | 0.30 |
| RSI | 41.98 |
| Earnings Date | Feb 25, 2026 |